Definity Financial (TSE:DFY) reported fourth-quarter and full-year 2025 results marked by strong underwriting performance and initial integration work following the recent closing of its acquisition ...
Definity Financial Corporation (TSX:DFY) presented its fourth quarter and full-year 2025 results on February 13, 2026, highlighting strong performance across key metrics and detailing progress on its ...
Definity Financial (TSX:DFY) has drawn investor attention after recent share price moves, with a 2.0% gain over the past week contrasting with a negative return over the past month and past 3 months.
Approval expands low-dose MRI contrast options for the youngest patients and reflects a positive benefit–risk profile of VUEWAY® injection from birth through adulthood PRINCETON, N.J., Feb. 23, 2026 ...
A tandem of homegrown Tucson drug-development companies plans to make its own drugs for testing at a new manufacturing plant — and eventually start producing their drugs here for worldwide ...
Brad Zukeran ’24 is pursuing a major in environmental science and minors in political science and history at Santa Clara University. Zukeran was a 2022-23 environmental ethics fellow at the Markkula ...
Avonex is a prescription drug that treats relapsing forms of multiple sclerosis (MS) in adults, such as relapsing-remitting MS, active secondary progressive MS, and clinically isolated syndrome.
Leqvio (inclisiran) may cause injection site reactions, including bruising, pain, discoloration, itchiness, and a burning or prickling sensation at the injection site. In addition to injection site ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results